WHO approves trials for two new Ebola vaccines amid deadly outbreak in DR Congo
The World Health Organization has approved clinical trials for two additional Ebola vaccine candidates as health workers try to contain an outbreak in Africa that has killed more than 5,300 people. The new trials are being added to an existing study that began last month using the Ervebo vaccine, which is approved for Ebola virus but not for the Bundibugyo virus driving the outbreak in the Democratic Republic of the Congo. WHO chief Tedros Adhanom Ghebreyesus said expert groups recommended the new candidates after reviewing the situation.The two vaccines are ChAdOx1 BDBV, developed by the University of Oxford with the... [Continue Reading]
360LiveNews | 04 Nov 2026 17:30 LONDON
Advert for a company owned by the publisher of 360LiveNews.
